Specifically, in EGFR-mutated lung cancer cell lines expressing high levels of AXL (PC9 and HCC4011 cells), a small population of tumor cells tolerant to osimertinib emerged as persisters by restoring the survival signal generated by AXL [37]. Here, AXL is linked to neoplasm.